This Statutory Rule is being issued free of charge to all known recipients of Statutory Rule 2006 No. 214 which contained an error.
2006 No. 214
DANGEROUS DRUGS
The Misuse of Drugs (Amendment) (No. 2) Regulations (Northern Ireland) 2006
Made 11th May 2006
Coming into operation 1st June 2006

The Department of Health, Social Services and Public Safety makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 1971, as adapted by section 38 of that Act and now vested in it.
1971 c. 38. Section 22 of that Act was amended by Section 177(1) of, and paragraph 12 of Schedule 4 to, the Customs and Excise Management Act 1979 (c. 2)
S.R. & O. (N.I.) 1973 No. 504; Article 5(a) and S.I. 1999/283 (N.I.1); Article 3(6)
In accordance with section 31(3) of that Act it has consulted with the Advisory Council on the Misuse of Drugs.

1 Citation and commencement
1 These Regulations may be cited as the Misuse of Drugs (Amendment) (No. 2) Regulations (Northern Ireland) 2006 and shall come into operation on 1st June 2006.
2 In these Regulations, “the 2002 Regulations” means the Misuse of Drugs Regulations (Northern Ireland) 2002.
S.R. 2002 No. 1; the relevant amending Regulations are S.R. 2003 No. 420 and S.R. 2005 No. 564

2 Interpretation
The Interpretation Act (Northern Ireland) 1954 shall apply to these Regulations as it applies to an Act of the Assembly.
1954 c. 33 (N.I.)

3 Amendment of regulation 2 of the 2002 Regulations
In regulation 2 of the 2002 Regulations (interpretation), in paragraph (1)—
(a) omit the definition of “extended formulary nurse prescriber”;
The definition of “extended formulary nurse prescriber” was inserted by regulation 3(2)(a) of S.R. 2003 No. 420 and substituted by regulation 4(1) of S.R. 2005 No. 564
(b) after the definition of “medicinal product” insert the following definition—

““nurse independent prescriber” has the same meaning as in the Prescription Only Medicines (Human Use) Order 1997, and such a person may only prescribe controlled drugs in accordance with regulation 6B;”

and
S.I. 1997/1830, to which there are amendments not relevant to these Regulations. The definition of nurse independent prescriber was inserted into the 1997 Order by the Medicines for Human Use (Prescribing) (Miscellaneous Amendments) Order 2006 (S.I. 2006 No. 915) and came into force on 1st May 2006
(c) in the definition of “prescription” for “an extended formulary nurse prescriber” substitute “a nurse independent prescriber”.
The definition of “prescription” was previously amended by regulation 3(2)(c) of S.R. 2003 No. 420, to include a reference to “extended formulary nurse prescriber”. Other amendments were also made by regulation 3(2)(b) of S.R. 2005 No. 119

4 Amendment of regulation 6B of the 2002 Regulations
In regulation 6B of the 2002 Regulations (Authority for Extended Formulary Nurse Prescribers to prescribe)—
(a) in the heading for the words “Extended Formulary Nurse Prescribers”, substitute “Nurse Independent Prescribers” and
(b) for “An extended formulary nurse prescriber” substitute “A nurse independent prescriber”.
(c) in sub-paragraph (a), omit “diazepam, lorazepam, midazolam,”;
(d) in sub-paragaph (e), at the end insert “, and”; and
(e) after sub-paragraph (e) insert—

“(f) diazepam, lorazepam or midazolam for use in palliative care of treatment of tonic-clonic seizures”

.
Regulation 6B was inserted by regulation 6 of S.R 2005 No. 564

5 Amendment of regulation 7 of the 2002 Regulations
In regulation of the 2002 Regulations (Administration of drugs in Schedules 2, 3, 4 and 5)—
(a) in paragraph (4) for “an extended formulary nurse prescriber” substitute “a nurse independent prescriber”; and
(b) in paragraph (5)—
(i) for “an extended formulary nurse prescriber” substitute “a nurse independent prescriber”, and
(ii) for “the extended formulary nurse prescriber” substitute “the nurse independent prescriber”.
Regulation 7 has been amended; paragraphs (4) and (5) were inserted by regulation 3(4) of S.R. 2003 No. 420 and substitued by regulation 7 of S.R. 2005 No. 564

6 Amendment of regulation 8 of the 2002 Regulations
In regulation 8(7) of the 2002 Regulations (Production and supply of drugs in Schedules 2 and 5), in paragraph (7) for “an extended formlary nurse prescriber” substitute “a nurse independent prescriber”.
Regulation 8 has been amended; paragraph (7) was inserted by regulation 3(5) of S.R. 2003 No. 420 and substituted by regulation 8 of S.R. 2005 No. 564

7 Amendment of regulation 9 of the 2002 Regulations
In regulation 9 of the 2002 Regulations (Production and supply of drugs in Schedules 3 and 4), in paragraph (7)—
(a) for “an extended formulary nurse prescriber” substitute “a nurse independent prescriber”; and
(b) in sub-paragraph (a) after “care” add “or treatment of tonic-clonic seizures”.
Regulation 9 has been amended; paragraph (7) was inserted by regulation 3(6) of S.R. 2003 No. 420 and substituted by regulation 9 of S.R. 2005 No. 564

8 Amendment of regulation 10 of the 2002 Regulations
In regulation 10(2) of the 2002 Regulations (Poession of drugs in Schedules 2, 3 and 4), in paragraph (2)—
(a) for “an extended formulary nurse prescriber” in both places those words appear, substitute “a nurse independent prescriber”; and
(b) in sub-paragraph (a) for “extended formulary nurse prescriber” in both places those words appear, substitute “nurse independent prescriber”.
Regulation 10 has been amended; paragraph (2) was amended by regulation 3(7) of S.R. 2003 No. 420 to include extended formulary nurse prescribers
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 11th May 2006.
Andrew Elliott A Senior Officer of the Department of Health, Social Services and Public Safety

(This note is not part of the Regulations)
These Regulations further amend the Misuse of Drugs Regulations (Northern Ireland) 2002 (“the 2002 Regulations”). Regulations 3 to 8 amend regulations 2, 6B and 7 to 10 of the 2002 Regulations to replace references to “extended formulary nurse prescribers” with references to “nurse independent prescribers”. The effect is that nurse independent prescribers will be allowed to prescribe, supply, possess, administer and give directions for the administration of specified controlled drugs in those circumstances, in which extended formulary nurse prescribers were previously able to.
Regulations 4(c) to (e) and 7(b) amend regulations 6B and 9 of the 2002 Regulations to allow nurse independent prescribers to prescribe and supply diazepam, lorazepam and midazolam for the treatment of tonic-clonic seizures.
A full regulatory impact assessment has not been produced for these regulations as is has no impact on the costs of business.